Patents by Inventor Lorraine Hanssen

Lorraine Hanssen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule
    Patent number: 7553484
    Abstract: The invention relates to methods and compositions for treating neural damage caused by injury or disease, by enhancing neural outgrowth and/or repair responses in the nervous system. Preferably, the methods and compositions utilize agents which interfere with the ability of the major histocompatibility complex (MHC) Class I molecule (MHC I) to inhibit neurite outgrowth. Such agents include antibodies directed to MHC I, MHC I fragments and/or analogs, and agents which interfere with MHC I interaction with its neuronal receptor and the receptor's signaling pathway.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: June 30, 2009
    Inventors: Daniel L. Kaufman, Lorraine Hanssen, Dan Zekzer
  • Modulating neuronal outgrowth via the major histocompatibility complex Class I (MHC I) molecule
    Publication number: 20030049254
    Abstract: The invention relates to methods and compositions for treating neural damage caused by injury or disease, by enhancing neural outgrowth and/or repair responses in the nervous system. Preferably, the methods and compositions utilize agents which interfere with the ability of the major histocompatibility complex (MHC) Class I molecule (MHC I) to inhibit neurite outgrowth. Such agents include antibodies directed to MHC I, MHC I fragments and/or analogs, and agents which interfere with MHC I interaction with its neuronal receptor and the receptor's signaling pathway.
    Type: Application
    Filed: June 5, 2002
    Publication date: March 13, 2003
    Inventors: Daniel L. Kaufman, Lorraine Hanssen, Dan Zekzer